From the Food and Drug Administration.
Nightingale
S L
SL
Office of Health Affairs, FDA, Rockville, MD 20857, USA.
D000485:Allergens / Q000276:immunology*; D019433:Chickenpox Vaccine; D014645:Herpesvirus 3, Human / Q000276:immunology*; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D007840:Latex; D008327:Mammography / Q000592:standards*; D011358:Product Surveillance, Postmarketing; D011786:Quality Control; D011933:Reagent Kits, Diagnostic; D014481:United States; D014486:United States Food and Drug Administration; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology
D000485:Allergens; D019433:Chickenpox Vaccine; D007840:Latex; D011933:Reagent Kits, Diagnostic; D014613:Vaccines, Attenuated; D014765:Viral Vaccines; D007073:Immunoglobulin E